Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways

Background/Aims: Gluconeogenesis, a reverse process of glycolysis, is suppressed in neoplastic livers. Cytoplasmic phosphoenolpyruvate carboxykinase (PEPCK-C/PCK1, encoded by PCK1) is a step limiting enzyme of gluconeogenesis. The induced expression of the factor is reported to initiate gluconeogene...

Full description

Bibliographic Details
Main Authors: Yufu Tang, Yibing Zhang, Chunhui Wang, Zhongyi Sun, Longfei Li, Shuqun Cheng, Wenping Zhou
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-05-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/489811
_version_ 1819078383144796160
author Yufu Tang
Yibing Zhang
Chunhui Wang
Zhongyi Sun
Longfei Li
Shuqun Cheng
Wenping Zhou
author_facet Yufu Tang
Yibing Zhang
Chunhui Wang
Zhongyi Sun
Longfei Li
Shuqun Cheng
Wenping Zhou
author_sort Yufu Tang
collection DOAJ
description Background/Aims: Gluconeogenesis, a reverse process of glycolysis, is suppressed in neoplastic livers. Cytoplasmic phosphoenolpyruvate carboxykinase (PEPCK-C/PCK1, encoded by PCK1) is a step limiting enzyme of gluconeogenesis. The induced expression of the factor is reported to initiate gluconeogenesis process and antagonize hepatocellular carcinoma (HCC). In the current study, the effect of the modulation of PCK1 expression on HCC was assessed. Methods: The levels of PCK1 in clinical HCC tissues and different HCC cell lines were investigated with real time quantitative PCR, immunochemistry, and western blotting. Thereafter, the expression of PCK1 gene was induced in two HCC cell lines and the effect of the overexpression on proliferation and migration potentials of HCC cells was detected with CCK-8 assay, flow cytometry, TUNEL staining, and transwell assay. The activities of glycolysis and gluconeogenesis pathways in PCK1-overexpressed HCC cell lines were detected with specific kits to underlie the mechanism by which PCK1 exerted its function. The results of the in vitro experiments were validated with HCC xenograft rat models. Results: The expression levels of PCK1 were suppressed in HCC samples and in cells derived from HCC tissues. According to the results of the in vitro assays, the overexpression of PCK1 decreased viability, induced apoptosis, and inhibited migration in both HCC cell lines. The effect was associated with the suppressed glycolysis and the induced gluconeogenesis pathways, represented by the enhanced production of glucose and the limited production of pyruvic acid, lactate, citrate, and malate. The results of the in vitro assays were confirmed in rat models in that the growth rate of solid HCC tumors was reduced in mice transplanted with PCK1-overexpressed HCC cells. Conclusion: Findings outlined in the current study demonstrated that activating gluconeogenesis process via PCK1 overexpression was a potential treating strategy against HCC.
first_indexed 2024-12-21T19:12:13Z
format Article
id doaj.art-645ad713cab046f6b645b31a78fdf97d
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-21T19:12:13Z
publishDate 2018-05-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-645ad713cab046f6b645b31a78fdf97d2022-12-21T18:53:10ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-05-0147134435510.1159/000489811489811Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis PathwaysYufu TangYibing ZhangChunhui WangZhongyi SunLongfei LiShuqun ChengWenping ZhouBackground/Aims: Gluconeogenesis, a reverse process of glycolysis, is suppressed in neoplastic livers. Cytoplasmic phosphoenolpyruvate carboxykinase (PEPCK-C/PCK1, encoded by PCK1) is a step limiting enzyme of gluconeogenesis. The induced expression of the factor is reported to initiate gluconeogenesis process and antagonize hepatocellular carcinoma (HCC). In the current study, the effect of the modulation of PCK1 expression on HCC was assessed. Methods: The levels of PCK1 in clinical HCC tissues and different HCC cell lines were investigated with real time quantitative PCR, immunochemistry, and western blotting. Thereafter, the expression of PCK1 gene was induced in two HCC cell lines and the effect of the overexpression on proliferation and migration potentials of HCC cells was detected with CCK-8 assay, flow cytometry, TUNEL staining, and transwell assay. The activities of glycolysis and gluconeogenesis pathways in PCK1-overexpressed HCC cell lines were detected with specific kits to underlie the mechanism by which PCK1 exerted its function. The results of the in vitro experiments were validated with HCC xenograft rat models. Results: The expression levels of PCK1 were suppressed in HCC samples and in cells derived from HCC tissues. According to the results of the in vitro assays, the overexpression of PCK1 decreased viability, induced apoptosis, and inhibited migration in both HCC cell lines. The effect was associated with the suppressed glycolysis and the induced gluconeogenesis pathways, represented by the enhanced production of glucose and the limited production of pyruvic acid, lactate, citrate, and malate. The results of the in vitro assays were confirmed in rat models in that the growth rate of solid HCC tumors was reduced in mice transplanted with PCK1-overexpressed HCC cells. Conclusion: Findings outlined in the current study demonstrated that activating gluconeogenesis process via PCK1 overexpression was a potential treating strategy against HCC.https://www.karger.com/Article/FullText/489811GluconeogenesisGlycolysisHepatocellular carcinomaPhosphoenolpyruvate carboxykinase 1
spellingShingle Yufu Tang
Yibing Zhang
Chunhui Wang
Zhongyi Sun
Longfei Li
Shuqun Cheng
Wenping Zhou
Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
Cellular Physiology and Biochemistry
Gluconeogenesis
Glycolysis
Hepatocellular carcinoma
Phosphoenolpyruvate carboxykinase 1
title Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
title_full Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
title_fullStr Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
title_full_unstemmed Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
title_short Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways
title_sort overexpression of pck1 gene antagonizes hepatocellular carcinoma through the activation of gluconeogenesis and suppression of glycolysis pathways
topic Gluconeogenesis
Glycolysis
Hepatocellular carcinoma
Phosphoenolpyruvate carboxykinase 1
url https://www.karger.com/Article/FullText/489811
work_keys_str_mv AT yufutang overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT yibingzhang overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT chunhuiwang overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT zhongyisun overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT longfeili overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT shuquncheng overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways
AT wenpingzhou overexpressionofpck1geneantagonizeshepatocellularcarcinomathroughtheactivationofgluconeogenesisandsuppressionofglycolysispathways